{
    "nctId": "NCT05403736",
    "briefTitle": "Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial",
    "officialTitle": "IIT2021-07-Atkins-CARMA: Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Number of participants who complete the cardio-oncology consultation visit",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Any stage (I-IV) malignancy being treated with high dose (\u226530 Gy) radiotherapy where the heart is in the treatment field.\n* Have Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2.\n* Planning to receive standard of care radiotherapy treatments.\n* Access to a smart device that has the capability to sync to the devices.\n* Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.\n* Ability to read, write and understand English.\n\nExclusion Criteria:\n\n* Known allergy to surgical steel or elastomer/rubber.\n* Heart attack within 6 months prior to study enrollment.\n* Severe and/or active scleroderma or systemic lupus erythematosus.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}